Bollard Group’s Avanos Medical AVNS Stock Holding History

Bollard Group’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,533	Closed	-$67K	–	233
2019 Q2	$67K	Hold	1,533	–	–	﹤0.01%	203
2019 Q1	$65K	Hold	1,533	–	–	﹤0.01%	202
2018 Q4	$69K	Buy	1,533 +80	+6%	+$4.19K	﹤0.01%	194
2018 Q3	$100K	Hold	1,453	–	–	﹤0.01%	193
2018 Q2	$83K	Hold	1,453	–	–	﹤0.01%	193
2018 Q1	$67K	Hold	1,453	–	–	﹤0.01%	201
2017 Q4	$67K	Hold	1,453	–	–	﹤0.01%	196
2017 Q3	$65K	Hold	1,453	–	–	﹤0.01%	206
2017 Q2	$57K	Hold	1,453	–	–	﹤0.01%	220
2017 Q1	$55K	Buy	1,453 +150	+12%	+$5.84K	﹤0.01%	219
2016 Q4	$48K	Hold	1,303	–	–	﹤0.01%	225
2016 Q3	$45K	Hold	1,303	–	–	﹤0.01%	218
2016 Q2	$42K	Hold	1,303	–	–	﹤0.01%	210
2016 Q1	$37K	Hold	1,303	–	–	﹤0.01%	214
2015 Q4	$44K	Sell	1,303 -394	-23%	-$12.3K	﹤0.01%	217
2015 Q3	$48K	Hold	1,697	–	–	﹤0.01%	233
2015 Q2	$69K	Hold	1,697	–	–	0.01%	222
2015 Q1	$83K	Sell	1,697 -310	-15%	-$14.4K	0.01%	218
2014 Q4	$91K	Buy	+2,007	New	+$78.9K	0.01%	206

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bollard Group's AVNS Position: Q3 2019 in Review

Bollard Group sold out of Avanos Medical (AVNS) in Q3 2019, closing a stake of 1,533 shares — an estimated $67K sold.

Bollard Group first reported a position in AVNS in Q4 2014 and held it in 19 quarters. The position peaked at $100K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

Bollard Group reported no remaining Avanos Medical position as of Q3 2019 after selling out during the quarter.
Bollard Group sold 1,533 Avanos Medical shares in Q3 2019, an estimated $67K.
Bollard Group first reported a position in Avanos Medical in Q4 2014 and held it in 19 quarters.
Bollard Group's Avanos Medical position peaked at $100K in Q3 2018.
290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Bollard Group's 13F filing for Q3 2019, filed 13 Nov 2019.